Hemgenix has long been supplied ‘conditional authorisation’. Which means that the European Medicines Company made the decision that the main advantages of Hemgenix are larger than its pitfalls, but the company must supply additional proof right after authorisation.Professionals observed that the volume of patients envisioned to receive etranaco